2021
DOI: 10.1007/s00404-021-06179-4
|View full text |Cite
|
Sign up to set email alerts
|

Effects of a disposable home electro-stimulation device (Pelviva) for the treatment of female urinary incontinence: a randomised controlled trial

Abstract: Aims To compare current General Medical Practitioner treatment as usual (TAU) for the treatment of female urinary incontinence with a novel disposable home electro-stimulation device (Pelviva). Methods Open label, Primary Care post-market evaluation. 86 women with urinary incontinence were randomly assigned to one of two 12-week treatments: TAU or Pelviva for 30 min every other day plus TAU. Outcome measures included ICIQ-UI (primary), PISQ-IR, PGI… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
2
0
3

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
1
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 20 publications
0
2
0
3
Order By: Relevance
“…Nors DDRP laikomi pirmosios eilės pasirinkimu (Aoki et al, 2017;Bø, 2020;Oldham et al, 2021), gydant įtampos šlapimo nelaikymą, tačiau vis dar diskutuojama dėl kitų intervencijų, tokių kaip elektrostimuliacijos (Bø, 2020), funkcinė magnetinės stimuliacijos (Dudonienė et al, 2023;Lukanović et al, 2021) veiksmingumo. Šlapimo nelaikymui sumažinti gali būti vartojami vaistai, švirkščiamos tūrinės medžiagos, botulino toksino injekcijos (Hagen et al, 2020).…”
Section: įVadasunclassified
“…Nors DDRP laikomi pirmosios eilės pasirinkimu (Aoki et al, 2017;Bø, 2020;Oldham et al, 2021), gydant įtampos šlapimo nelaikymą, tačiau vis dar diskutuojama dėl kitų intervencijų, tokių kaip elektrostimuliacijos (Bø, 2020), funkcinė magnetinės stimuliacijos (Dudonienė et al, 2023;Lukanović et al, 2021) veiksmingumo. Šlapimo nelaikymui sumažinti gali būti vartojami vaistai, švirkščiamos tūrinės medžiagos, botulino toksino injekcijos (Hagen et al, 2020).…”
Section: įVadasunclassified
“…The disorder denominated urinary incontinence (UI) has been diagnosed amongst 25-45% of women worldwide [1,2]. Pathologically, UI possesses various etiologies and predisposing factors, such as obesity, pregnancy, childbirth, smoking, age/menopause, and genetics.…”
Section: Introductionmentioning
confidence: 99%
“…UI negatively affects the quality of life of those that are affected by this problem, which consequently places a burden on health services [3]. The disease is classified into three basic types: stress urinary incontinence (SUI), related to increased abdominal pressure; urge urinary incontinence (UUI), related to overactive bladder; mixed urinary incontinence (MUI), related to involuntary leakage associated with urgency and exertion [2,3]. Although it is known that coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has a wide range of clinical manifestations such as respiratory muscle weakness and generalized fatigue, there are rare, documented cases in the scientific literature that associate the disease with UI [4][5][6].…”
Section: Introductionmentioning
confidence: 99%
“…A responsividade do PISQ-IR já foi avaliada e comprovada 81,82 . Após tratamento cirúrgico ou conservador houve melhora A aplicabilidade do PISQ-IR vem sendo comprovada em diversos estudos 33,83,84,85,86,87,88,89,90,91…”
Section: Discussionunclassified
“…Outro estudo avaliou o impacto da auto-aplicação domiciliar de eletroestimulação vaginal, com dispositivo descartável (Pelviva®). Houve melhora na função sexual de mulheres SA, especificamente do score SA-CI90 .Em paciente com IA o PISQ-IR foi utilizado na avaliação do impacto do tratamento com eletroestimulação do nervo tibial percutânea versus placebo. Em comparação ao placebo a eletroestimulação percutânea não resultou em melhora significativa nos sintomas, número de episódios de incontinência ou função sexual91 .Esses estudos ressaltam a importância do uso de questionários de sexualidade específicos para DAP na avaliação de pacientes com essas disfunções.…”
unclassified